Fig. 7From: Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapyRepresentative MIC/sMIC abundance in metastatic melanoma tumors. The presence of MIC/sMIC was detected on TMA with a MIC (A/B)-specific antibody D4H3. Left panel, low magnification of TMA staining images. Right, higher magnification of TMA staining imagesBack to article page